| 000 | 00952nam a2200253 4500 | ||
|---|---|---|---|
| 001 | 4139 | ||
| 090 | _a4139 | ||
| 100 | _a20190412d1984 k||y0pory50 ba | ||
| 101 | _aeng | ||
| 102 |
_aGB _bLondres |
||
| 106 | _ar | ||
| 200 |
_aReviews on Endocrine-Related Cancer _fR.D. Bullbrook _fK. Griffiths _fR.J.B. King _fW.L. McGuire _fO.H. Pearson _fS. Saez _vVol. 18 |
||
| 210 |
_aLondres _cPharmaceuticals Division of ICI _d1984 |
||
| 215 |
_a37 p. _d24,1 cm |
||
| 327 | _aManagement of serosal effusions in cancer; Cell kinetic and ER assays in breast cancer; Prospects for tumour monitoring by immunological markers; Growth factors, hormones, oncogenes and cancer. | ||
| 606 | _aCancro da mama | ||
| 675 | _a618.19-006 | ||
| 700 | _aBulbrook, R.D. | ||
| 701 |
_4aut _aGriffiths, K. |
||
| 701 |
_4aut _aKing, R.J.B. |
||
| 701 |
_4aut _aMcGuire, W.L. |
||
| 701 |
_4aut _aPearson, O.H. |
||
| 701 |
_4aut _aSaez, S. |
||
| 942 | _cAM | ||